WHAT IS PART OF AN EXPERIMENTAL STUDY LOOKING FOR THE TREATMENT OF MESOTHELIOMA?

 

The new drugs are evaluated in mesothelioma, Drugs directed against specific molecules including Helping the cell surface molecules, Tumor blood vessels feeding Involved in the tumor, and molecular Immune response against tumors. Epidermal growth Factor is part of the trip to help mesothelioma. Development, and connecting EGF molecule drug Intervention of the cell (the recipient, EGFR) Growth path. In most cases it DNA mutations or errors in the receiver These medications work, because it is not a mistake, Mesothelioma, EGFR and confirmed by testing Inhibitors in this disease is not encouraging. Another factor related to the development of platelet PDGF also has an objective test. Barrel Endothelial growth factor is useful in the tumor blood They get more oxygen and nutrients, and the ship There are several drugs that try to protect. These characteristics of the tumor. Some drugs It is used for some of these very small molecules Proteins, called antibodies to interfere Either a growth factor or consignee. There are several. Characteristics using antibodies linked to toxic proteins and molecules associated with mesothelioma Protein, to select the goals for this mesothelioma And normal tissue. Specific proteins have Found to be associated with a unique mesothelioma And studies have The patient, a protein vaccine - try it. "Activates" trying to test vaccine Suppression of the immune system in mesothelioma The use of immune cells to kill the tumor. About the operation, there are also new therapies As the abdomen and chest with a bath A hot solution containing chemotherapy Tried to kill living cells. Experimental procedure The investigation is still no result. This book will be read once Plan for new molecules mesothelioma. You must check a doctor exclusively for you New tests as needed, and then you can decide After listening to and participating in clinical trials The risks and benefits.